![origenis_logo_Pantone [Konvertiert]_2020](https://static.wixstatic.com/media/9afeac_83ea95f8f63144538d48a310b96d7f33~mv2.png/v1/fill/w_260,h_53,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/origenis_logo_Pantone%20%5BKonvertiert%5D_2020.png){kind=logo}
Origenis receives Grant by the BmBF to Deepen Research in the Anti-inflammatory Sector
- 15. März 2009
- 1 Min. Lesezeit
March 15, 2009
Origenis receives a research grant from the Federal Ministry of Education and Research to extend its research in the antiinflammatory area. Within this project a consortium of experts, led by Origenis, develops small molecules against the interleukin-mediated autoimmune disease Colitis ulcerosa. The grant will provide a non-repayable fund to Origenis in the amount of 1.2 million €.